| |||||||||||
Supplementary Material
Supplements to: Cooper DA et al. Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection. N Engl J Med 2008;359:355-65.
These appendixes have been provided by the authors to give readers additional information about their work.
Download PDF File of Supplementary Appendix 1: Members of the BENCHMRK (Blocking Integrase in Treatment Experienced Patients with a Novel Compound against HIV, Merck) Study Teams.
Download PDF File of Supplementary Appendix 2: Supplementary Figures.
| |||||||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |